| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF4724-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-06157-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-98453-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-99635-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-06516-50ul | |||
![Western Blot: 14-3-3 beta Antibody (05) [NBP3-06157] - Anti-YWHAB mouse monoclonal antibody at 1:500 dilution Lane A: Hela Whole Cell Lysate Lane B: HepG2 Whole Cell Lysate Lysates/proteins at 30 ug per lane. Secondary: Goat Anti-Mouse IgG H&L (Dylight800) at 115000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size:28 kDa Observed band size:32 kDa](http://images.novusbio.com/fullsize/14-3-3-beta-Antibody-05-Western-Blot-NBP3-06157-img0001.jpg "Western Blot: 14-3-3 beta Antibody (05) [NBP3-06157] - Anti-YWHAB mouse monoclonal antibody at 1:500 dilution Lane A: Hela Whole Cell Lysate Lane B: HepG2 Whole Cell Lysate Lysates/proteins at 30 ug per lane. Secondary: Goat Anti-Mouse IgG H&L (Dylight800) at 115000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size:28 kDa Observed band size:32 kDa")
![14-3-3 beta Antibody (05) [NBP3-06157] - cynoYWHAB was immunoprecipitated using: Lane A: 0.5 mg HepG2 Whole Cell Lysate Lane B: 0.5 mg Hela Whole Cell Lysate 2 uL anti-cyno YWHAB mouse monoclonal antibody and 15 ul of 50 % Protein G agarose. Primary antibody:Anti-cyno YWHAB mouse monoclonal antibody, at 1:200 dilution Secondary antibody: Dylight 800-labeled antibody to Mouse IgG (H+L), at 1:7500 dilution Developed using the odssey technique. Performed under reducing conditions. Predicted band size: 32 kDa Observed band size: 32 kDa](http://images.novusbio.com/fullsize/14-3-3-beta-Antibody-05-NBP3-06157-img0002.jpg)
![Western Blot: 14-3-3 beta Antibody [NBP2-98453] - Anti-14-3-3 beta rabbit polyclonal antibody at 1:500 dilution. Lane A: HepG2 Whole Cell Lysate. Lane B: Hela Whole Cell Lysate. Lane C: NCI-H1299 Whole Cell Lysate. Lane D: A431 Whole Cell Lysate. Lysates/proteins at 30 ug per lane. Secondary Goat Anti- Rabbit IgG H&L (Dylight 800) at 1/10000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size: 28 kDa. Observed band size: 32 kDa (We are unsure as to the identity of these extra bands).](http://images.novusbio.com/fullsize/14-3-3-beta-Antibody-Western-Blot-NBP2-98453-img0003.jpg "Western Blot: 14-3-3 beta Antibody [NBP2-98453] - Anti-14-3-3 beta rabbit polyclonal antibody at 1:500 dilution. Lane A: HepG2 Whole Cell Lysate. Lane B: Hela Whole Cell Lysate. Lane C: NCI-H1299 Whole Cell Lysate. Lane D: A431 Whole Cell Lysate. Lysates/proteins at 30 ug per lane. Secondary Goat Anti- Rabbit IgG H&L (Dylight 800) at 1/10000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size: 28 kDa. Observed band size: 32 kDa (We are unsure as to the identity of these extra bands).")
![Immunoprecipitation: 14-3-3 beta Antibody [NBP2-98453] - 14-3-3 beta was immunoprecipitated using: Lane A: 0.5 mg HepG2 Whole Cell Lysate. Lane B: 0.5 mg Hela Whole Cell Lysate. 4 ul anti-14-3-3 beta rabbit polyclonal antibody and 15 ul of 50 % Protein G agarose. Primary antibody: Anti-14-3-3 beta rabbit polyclonal antibody, at 1:100 dilution. Secondary antibody: Dylight 800-labeled antibody to rabbit IgG (H+L), at 1:5000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size: 32 kDa. Observed band size: 32 kDa](http://images.novusbio.com/fullsize/14-3-3-beta-Antibody-Immunoprecipitation-NBP2-98453-img0001.jpg)
![Western Blot: 14-3-3 beta Antibody [NBP2-99635] - Anti-14-3-3 beta rabbit polyclonal antibody at 1:500 dilution. Lane A: Hela Whole Cell Lysate. Lane B: HepG2 Whole Cell Lysate. Lysates/proteins at 30 ug per lane. Secondary Goat Anti-Rabbit IgG H&L (Dylight 800) at 1/10000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size: 28 kDa. Observed band size: 34 kDa (We are unsure as to the identity of these extra bands).](http://images.novusbio.com/fullsize/14-3-3-beta-Antibody-Western-Blot-NBP2-99635-img0003.jpg "Western Blot: 14-3-3 beta Antibody [NBP2-99635] - Anti-14-3-3 beta rabbit polyclonal antibody at 1:500 dilution. Lane A: Hela Whole Cell Lysate. Lane B: HepG2 Whole Cell Lysate. Lysates/proteins at 30 ug per lane. Secondary Goat Anti-Rabbit IgG H&L (Dylight 800) at 1/10000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size: 28 kDa. Observed band size: 34 kDa (We are unsure as to the identity of these extra bands).")
![Immunoprecipitation: 14-3-3 beta Antibody [NBP2-99635] - 14-3-3 beta was immunoprecipitated using: Lane A: 0.5 mg Hela Whole Cell Lysate. Lane B: 0.5 mg HepG2 Whole Cell Lysate. 2 ul anti-14-3-3 beta rabbit polyclonal antibody and 15 ul of 50 % Protein G agarose. Primary antibody: Anti-14-3-3 beta rabbit polyclonal antibody, at 1:200 dilution. Secondary antibody: Dylight 800-labeled antibody to rabbit IgG (H+L), at 1:5000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size: 28 kDa. Observed band size: 28 kDa](http://images.novusbio.com/fullsize/14-3-3-beta-Antibody-Immunoprecipitation-NBP2-99635-img0004.jpg)
![Flow Cytometry: 14-3-3 beta Antibody (03) [NBP3-06516] - Analysis of Human YWHAB expression on Molt-4 cells. The cells were treated, stained with purified anti-Human YWHAB, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.](http://images.novusbio.com/fullsize/14-3-3-beta-Antibody-03-Flow-Cytometry-NBP3-06516-img0002.jpg "<b>Biological Strategies Validation. </b>Flow Cytometry: 14-3-3 beta Antibody (03) [NBP3-06516] - Analysis of Human YWHAB expression on Molt-4 cells. The cells were treated, stained with purified anti-Human YWHAB, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.")